MD Anderson Cancer center — Houston, Texas

MD Anderson Cancer center is a clinical research site located in Houston, Texas, United States.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Carcinoma, Hepatocellular, HER2-positive Metastatic Breast Cancer.

Sponsors: FDA Office of Orphan Products Development, Abramson Cancer Center at Penn Medicine.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer center?

MD Anderson Cancer center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer center conducted?

MD Anderson Cancer center has 2 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Hepatocellular, HER2-positive Metastatic Breast Cancer.

Is MD Anderson Cancer center accredited by Crixeo Health?

MD Anderson Cancer center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.